Literature DB >> 20035231

Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study.

Tracy R Glass1, Manuel Battegay, Matthias Cavassini, Sabina De Geest, Hansjakob Furrer, Pietro L Vernazza, Bernard Hirschel, Enos Bernasconi, Martin Rickenbach, Huldrych F Günthard, Heiner C Bucher.   

Abstract

BACKGROUND: Adherence to combination antiretroviral therapy (cART) is a dynamic process, however, changes in adherence behavior over time are insufficiently understood.
METHODS: Data on self-reported missed doses of cART was collected every 6 months in Swiss HIV Cohort Study participants. We identified behavioral groups associated with specific cART adherence patterns using trajectory analyses. Repeated measures logistic regression identified predictors of changes in adherence between consecutive visits.
RESULTS: Six thousand seven hundred nine individuals completed 49,071 adherence questionnaires [median 8 (interquartile range: 5-10)] during a median follow-up time of 4.5 years (interquartile range: 2.4-5.1). Individuals were clustered into 4 adherence groups: good (51.8%), worsening (17.4%), improving (17.6%), and poor adherence (13.2%). Independent predictors of worsening adherence were younger age, basic education, loss of a roommate, starting intravenous drug use, increasing alcohol intake, depression, longer time with HIV, onset of lipodystrophy, and changing care provider. Independent predictors of improvements in adherence were regimen simplification, changing class of cART, less time on cART, and starting comedications.
CONCLUSIONS: Treatment, behavioral changes, and life events influence patterns of drug intake in HIV patients. Clinical care providers should routinely monitor factors related to worsening adherence and intervene early to reduce the risk of treatment failure and drug resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20035231     DOI: 10.1097/QAI.0b013e3181ca48bf

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  52 in total

1.  Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.

Authors:  Dean G Cruess; Seth C Kalichman; Christine Amaral; Connie Swetzes; Chauncey Cherry; Moira O Kalichman
Journal:  Ann Behav Med       Date:  2012-04

2.  Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV.

Authors:  Dominique Cadosch; Sebastian Bonhoeffer; Roger Kouyos
Journal:  J R Soc Interface       Date:  2012-03-14       Impact factor: 4.118

Review 3.  HIV treatment as prevention in men who have sex with men: examining the evidence.

Authors:  Patrick O'Byrne; Paul MacPherson
Journal:  CMAJ       Date:  2015-12-22       Impact factor: 8.262

4.  Uropathogen Resistance and Antibiotic Prophylaxis: A Meta-analysis.

Authors:  Rachel E Selekman; Daniel J Shapiro; John Boscardin; Gabrielle Williams; Jonathan C Craig; Per Brandström; Marco Pennesi; Gwenalle Roussey-Kesler; Pankaj Hari; Hillary L Copp
Journal:  Pediatrics       Date:  2018-07       Impact factor: 7.124

Review 5.  A Review of HIV-Specific Patient-Reported Outcome Measures.

Authors:  Kim Engler; David Lessard; Bertrand Lebouché
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

Review 6.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

7.  Variable Selection in Threshold Regression Model with Applications to HIV Drug Adherence Data.

Authors:  Takumi Saegusa; Tianzhou Ma; Gang Li; Ying Qing Chen; Mei-Ling Ting Lee
Journal:  Stat Biosci       Date:  2020-06-17

8.  Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use.

Authors:  Aaron J Blashill; Janna R Gordon; Steven A Safren
Journal:  J Behav Med       Date:  2012-11-22

9.  Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.

Authors:  Jean-Jacques Parienti; Aurélie Barrail-Tran; Xavier Duval; Georges Nembot; Diane Descamps; Marie Vigan; Bernard Vrijens; Xavière Panhard; Anne-Marie Taburet; France Mentré; Cécile Goujard
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  Chronic binge alcohol consumption does not diminish effectiveness of continuous antiretroviral suppression of viral load in simian immunodeficiency virus-infected macaques.

Authors:  Patricia E Molina; Angela M Amedee; Ron Veazey; Jason Dufour; Julia Volaufova; Gregory J Bagby; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2014-09       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.